Clinical Trial Update: A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression). [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the long-term safety and tolerability of an investigational drug for depressive episodes in Bipolar I disorder was terminated; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Depressive Episodes, Bipolar I Depression | Phase 3 | Status: TERMINATED | Results posted: 2025-02-21